Concepedia

Wei Li

WL

Statistics

Publications

10

Citations

278

H-Index

10

Active since

2013

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Karolinska Institutet

Chinese Academy of Medical Sciences & Peking Union Medical College

Institute of Hematology & Blood Diseases Hospital

BGI Group (China)

Wei Li is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2013–2022

10

Publications

10

Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes

Wei Li, Yu-Kai Su, Chien‐Min Lin et al. · Oncotarget · 2016 · 59 citations · Full text

, , +17

Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas

Xiaofei Ye, Weicheng Ren, Dongbing Liu et al. · The Journal of Experimental Medicine · 2020 · 45 citations · Full text

, , +17

Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells

Dongmei Fan, Wei Li, Yuqi Yang et al. · Journal of Hematology & Oncology · 2015 · 33 citations · Full text

, , +17

Knockdown of long non‐coding RNA linc‐ITGB1 inhibits cancer stemness and epithelial‐mesenchymal transition by reducing the expression of Snail in non‐small cell lung cancer

Lili Guo, Cen-Cen Sun, Shilei Xu et al. · Thoracic Cancer · 2018 · 31 citations · Full text

, , +17

Identification of hub genes in diabetic kidney disease via multiple-microarray analysis

Yumin Zhang, Wei Li, Yunting Zhou · Annals of Translational Medicine · 2020 · 30 citations · Full text

, , +17

1–5 of 10